Skip to main content

Alexion to Present at the UBS Global Life Sciences Conference

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the UBS Global Life Sciences Conference in New York City at 1:30 p.m. ET on Tuesday, September 21, 2010.

An audio webcast of Dr. Bell’s remarks will be available live. You can access the webcast at: www.alexionpharm.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

[ALXN-G]

Contacts:

Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Sr. Director, Corporate Communications
or
Media:
Makovsky + Company
Mark Marmur, 212-508-9670
or
Investors:
Rx Communications
Rhonda Chiger, 917-322-2569

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.